Approval · Notice of Compliance 34485 · 2024
TEVA-DEXTROAMPHETAMINE SR: Notice of Compliance 34485
Issued December 4, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34485
- Date
- December 4, 2024
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-DEXTROAMPHETAMINE SR | Not yet assigned | — |
Medicinal ingredients
- DEXTROAMPHETAMINE SULFATE 10 MG per CAP
- DEXTROAMPHETAMINE SULFATE 15 MG per CAP